GenapSys, Inc. is committed to a new era of applied genomic testing and a new paradigm for medical sequencing. We are developing a cost-disruptive, easy-to-use genomic diagnostic system based on our simple label-free proprietary GENIUS™ technology which delivers 100x improvement in cost and speed. These innovations will enable a new era of medicine through the widespread acquisition of genomic data for research and testing of genetic disease, cancer, and microbes.

Research Grants 11 show all


$1.7M
2012

$1M
2013

$1M
2014

$659.8K
2015

$604.1K
2016

Patents 128show all

  • 60
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 40
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 31
    B01L - Chemical or physical laboratory apparatus for general use
  • 27
    B03C - Magnetic or electrostatic separation of solid materials from solid materials or fluids
  • 23
    C40B - Combinatorial chemistry
  • 19
    H01L - Semiconductor devices
  • 16
    B01D - Separation
  • 15
    C12N - Microorganisms or enzymes
  • 11
    A61K - Preparations for medical, dental, or toilet purposes
  • 9
    B01J - Chemical or physical processes, e.g. catalysis or colloid chemistry

Contact Information

200 Cardinal Way Third Floor
Redwood City, CA 94063
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$249,000,00051-1002020-02-06Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2020-02-06$75,000,000Series UnknownOxford Finance LLC
2019-11-21$90,000,000Series CForesite Capital
2018-01-15$32,500,000Series C
2012-09-01$5,500,000Grant
2017-03-30Convertible Note
2013-03-22$8,500,000Series ADecheng Capital
2013-11-14$37,500,000Series BIPV CapitalDecheng Capital
2012-05-18Convertible NotePlug and Play